Inovio Pharmaceuticals, Inc. ( INO) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 25, 2026 12:40 PM EST ...

A team led by Professor Shoichiro Asayama at Tokyo Metropolitan University has synthesized a charge-free molecule designed to ...

Getting DNA into a living cell sounds simple, until you remember the cell’s outer membrane acts like a guarded wall. DNA ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) in a precedential decision on Friday reversed a district court’s ...

New workflow validated on Dynamic Devices Lynx® delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes ...

Collaborations with top automation, sequencing, & technology partners highlight Omega's commitment to advancing ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...

The rise of gene editing forces regulators to confront a difficult question: How to protect fair play in the age of genomic medicine.

A new DNA immunotherapy, Elenagen, doubled survival (13 to 25+ months) for tough ovarian cancers when added to chemotherapy, with fewer side effects.

The new product offering will supply global life science researchers with performance and reliability in multi-fragment ...

Based on these challenges, a comprehensive reassessment of how AI should be deployed in electrocatalysis has become urgently needed. Addressing this need, a review published (DOI: 10.1016/j.esci.2025.

ATLANTA, GA, UNITED STATES, February 3, 2026 /EINPresswire.com/ — New Ebook “Command the Room Without Performance” Challenges Modern Leadership Myths, Introduces Governed Authority™ Stephanie Chosen ...